140 related articles for article (PubMed ID: 26309402)
1. Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma.
Hrynyk M; Ellis JP; Haxho F; Allison S; Steele JA; Abdulkhalek S; Neufeld RJ; Szewczuk MR
Drug Des Devel Ther; 2015; 9():4573-86. PubMed ID: 26309402
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
Allison Logan S; Brissenden AJ; Szewczuk MR; Neufeld RJ
Drug Des Devel Ther; 2017; 11():2239-2250. PubMed ID: 28814832
[TBL] [Abstract][Full Text] [Related]
3. Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma.
Haxho F; Allison S; Alghamdi F; Brodhagen L; Kuta VE; Abdulkhalek S; Neufeld RJ; Szewczuk MR
Breast Cancer (Dove Med Press); 2014; 6():191-203. PubMed ID: 25525387
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma.
Abdulkhalek S; Geen OD; Brodhagen L; Haxho F; Alghamdi F; Allison S; Simmons DJ; O'Shea LK; Neufeld RJ; Szewczuk MR
Clin Transl Med; 2014 Dec; 3(1):28. PubMed ID: 26932374
[TBL] [Abstract][Full Text] [Related]
5. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
[TBL] [Abstract][Full Text] [Related]
6. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2.
Ucar B; Acar T; Arayici PP; Derman S
Nanotechnology; 2021 Sep; 32(48):. PubMed ID: 34375967
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro.
Ma J; Shen M; Xu CS; Sun Y; Duan YR; Du LF
Oncotarget; 2016 Nov; 7(48):80008-80018. PubMed ID: 27835907
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle formulation of ormeloxifene for pancreatic cancer.
Khan S; Chauhan N; Yallapu MM; Ebeling MC; Balakrishna S; Ellis RT; Thompson PA; Balabathula P; Behrman SW; Zafar N; Singh MM; Halaweish FT; Jaggi M; Chauhan SC
Biomaterials; 2015; 53():731-43. PubMed ID: 25890768
[TBL] [Abstract][Full Text] [Related]
9. Sialylation transmogrifies human breast and pancreatic cancer cells into 3D multicellular tumor spheroids using cyclic RGD-peptide induced self-assembly.
Akasov R; Haq S; Haxho F; Samuel V; Burov SV; Markvicheva E; Neufeld RJ; Szewczuk MR
Oncotarget; 2016 Oct; 7(40):66119-66134. PubMed ID: 27608845
[TBL] [Abstract][Full Text] [Related]
10. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir phosphate loaded pegylated-Eudragit nanoparticles for lung cancer therapy: Characterization, prolonged release, cytotoxicity profile, apoptosis pathways and in vivo anti-angiogenic effect by using CAM assay.
Yurtdaş-Kırımlıoğlu G; Güleç K; Görgülü Ş; Kıyan HT
Microvasc Res; 2022 Jan; 139():104251. PubMed ID: 34520775
[TBL] [Abstract][Full Text] [Related]
12. PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy.
Byeon HJ; Kim I; Choi JS; Lee ES; Shin BS; Youn YS
Int J Nanomedicine; 2015; 10():739-48. PubMed ID: 25632232
[TBL] [Abstract][Full Text] [Related]
13. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
14. Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.
Wang K; Zhang X; Zhang L; Qian L; Liu C; Zheng J; Jiang Y
Drug Deliv; 2015 May; 22(3):389-99. PubMed ID: 24670095
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
Daman Z; Faghihi H; Montazeri H
Drug Dev Ind Pharm; 2018 Sep; 44(9):1434-1442. PubMed ID: 29619850
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic angiogenesis by local sustained release of microRNA-126 using poly lactic-co-glycolic acid nanoparticles in murine hindlimb ischemia.
Tsumaru S; Masumoto H; Minakata K; Izuhara M; Yamazaki K; Ikeda T; Ono K; Sakata R; Minatoya K
J Vasc Surg; 2018 Oct; 68(4):1209-1215. PubMed ID: 29242072
[TBL] [Abstract][Full Text] [Related]
17. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo.
Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K
Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594
[TBL] [Abstract][Full Text] [Related]
18. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
[TBL] [Abstract][Full Text] [Related]
19. In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.
Nieto K; Pei P; Wang D; Mallery SR; Schwendeman SP
Int J Pharm; 2018 Mar; 538(1-2):48-56. PubMed ID: 29170116
[TBL] [Abstract][Full Text] [Related]
20. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]